Fernando Caravaca-Fontan
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Complement 3 Glomerulopathy Revisited: Bridging Pathogenesis and Therapy in the New Era.
Journal: Advances in kidney disease and health
Published: February 11, 2026
Targeting CD20 for B-cell Depletion in Autoimmune Kidney Disease: Next Generation.
Journal: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
Published: August 25, 2025
Severe hypertension with thrombotic microangiopathy: the need for pathogenically targeted treatments.
Journal: Kidney international
Published: May 14, 2025
Is the NefIgArd trial a paradigm shift in the treatment of IgA nephropathy?
Journal: Kidney international
Published: January 21, 2023
Update on C3 Glomerulopathy: A Complement-Mediated Disease.
Journal: Nephron
Published: November 25, 2019
Successful correction of metabolic acidosis is difficult to achieve in chronic kidney disease.
Journal: Nefrologia
Published: May 20, 2019
Detrimental effect of renin-angiotensin blockade on progression of chronic kidney disease at later stages: A matter of dosage adjustment?
Journal: Nefrologia
Published: September 06, 2018
Association of hyperkalemia with clinical outcomes in advanced chronic kidney disease.
Journal: Nefrologia
Published: June 25, 2018
Monoclonal gammopathies of renal significance.
Journal: Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia
Published: December 16, 2016
Tumor lysis syndrome in solid tumors: Clinical characteristics and prognosis.
Journal: Medicina clinica
Published: July 25, 2016
Last Updated: 09/26/2026